Y-Intercept (HK)’s Rallybio RLYB Stock Holding History

Y-Intercept (HK)’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,811	Closed	-$127K	–	1732
2024 Q2	$127K	Buy	+11,811	New	+$160K	0.01%	1233

Other funds holding RLYB

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Y-Intercept (HK)'s RLYB Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 11,811 shares — an estimated $127K sold.

Y-Intercept (HK) first reported a position in RLYB in Q2 2024 and held it in 1 quarter. The position peaked at $127K in Q2 2024. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

Y-Intercept (HK) reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 11,811 Rallybio shares in Q3 2024, an estimated $127K.
Y-Intercept (HK) first reported a position in Rallybio in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s Rallybio position peaked at $127K in Q2 2024.
49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.